Insiders who reported open-market trades in the last 12 months at the companies Jonathan Robert Hunt files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jonathan Robert Hunt is a corporate insider, tracked as Chief Accounting Officer of Perspective Therapeutics, Inc. (CATX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jonathan Robert Hunt last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 3 filings going back to 2024.
Has Jonathan Robert Hunt been buying or selling stock?
Recorded transactions: 5 open-market purchases ($71K) and 0 open-market sales across all tracked filings.
Jonathan Robert Hunt is Chief Accounting Officer of Perspective Therapeutics, Inc. (CATX). 3 SEC Form 4 filings on record going back to 2024, most recently on 4 March 2026. Most recent open-market trade: bought $22K of CATX on 17 November 2025. Lifetime open-market purchases: $71K.
Recent transactions
5
The latest 5 SEC Form 4 transactions reported by Jonathan Robert Hunt.
InsiderAlpha's records for Jonathan Robert Hunt go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. The typical open-market purchase is $14K (5 buys totaling $71K). The largest single buy on record is $39K of CATX in 2024. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
